CSANZ 2020

Sponsored Podcasts

Sponsored Podcasts will be available to registered health care professionals to listen throughout the meeting but will also be live streamed at the times indicated below

10.35 - 10.45am, Friday 11 December  



Q&A with international expert, Cardiologist Professor Keith Fox

Speaker: Professor Keith Fox

Listen to world renowned cardiologist, Dr Keith Fox, Professor of Cardiology, University of Edinburgh and founding fellow of the European Society of Cardiology, discuss his perspectives on the challenges of managing complex NVAF patients with renal impairment.

Bayer Australia Ltd. ABN 22 000 138 714,  875 Pacific Highway, Pymble NSW 2073. Xarelto® is a registered trademark of Bayer Group, Germany. PP-XAR-AU-0750-1. Prepared Nov 2020.

10.45 - 10.55am, Friday 11 December


Title to be confirmed

Speaker: To be confirmed

2.25 - 2.35pm, Friday 11 December

Dr David Roy Talks with Prof Lars Søndergaard: Should we be focusing our attention in TAVI to now move towards picking right valve for the right patient?

Speakers: Dr. David Roy & Professor Lars Søndergaard

This Podcast explores optimising patient outcomes with TAVI. Dr. David Roy is speaking with internationally renowned TAVI expert, Prof Lars Søndergaard from Denmark, on how we should be moving to the next era of TAVI intervention in Australia – by optimising patient outcomes, where we pick the right valve for the right patient. Additionally, we discuss the clinical outcome and design features of available TAVI in Australia.

10.40 - 10.50am, Saturday 12 December


New Treatment Options in Hyperkalaemia Management 

Speaker: Professor Matthew Weir

Vifor Pharma are proud to introduce Professor Matthew Weir, Chief of Nephrology at the University of Marlyand and world renowned speaker as he discusses new treatment options in Hyperkalaemia Management. Dr. Weir currently reviews manuscripts for more than 30 major medical journals, including the American Society of Nephrology, and Archives of Internal Medicine.  He is on the editorial board of 18 journals and is Section Editor of Current Hypertension Reports and Current Opinion in Hypertension and Nephrology, and Associate Editor of Clinical Nephrology and the American Journal of Nephrology.  In addition, he is a member of numerous associations, including the American Society of Nephrology, the National Kidney Foundation, the American Heart Association, and the American Society of Transplantation.  

2.30 - 2.40pm, Saturday 12 December

Have the Europeans lost the plot!! – An Australian perspective on the changes to the 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting    without persistent ST-segment elevation

Speakers: Dr Chris Hammett and Dr Sidney Lo

A quick discussion on the 2020 ESC guidelines from an Australian perspective.